Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae.
暂无分享,去创建一个
[1] Xilin Zhao,et al. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J. Blondeau,et al. Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[3] J. Domagala,et al. Mutant Prevention Concentration as a Measure of Fluoroquinolone Potency against Mycobacteria , 2000, Antimicrobial Agents and Chemotherapy.
[4] B. Kreiswirth,et al. Mutant Prevention Concentration as a Measure of Antibiotic Potency: Studies with Clinical Isolates ofMycobacterium tuberculosis , 2000, Antimicrobial Agents and Chemotherapy.
[5] K. Drlica. The future of fluoroquinolones , 2000, Annals of medicine.
[6] J. Rotschafer,et al. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model , 1994, Antimicrobial Agents and Chemotherapy.
[7] N. Georgopapadakou,et al. Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity , 1980, Antimicrobial Agents and Chemotherapy.
[8] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[9] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .